$FOR
Forestar Group Inc. Stock $for

$for Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000140658724000008 Filed on January 24, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$333.8M	$305.9M
YoY Change	10.71%	41.16%
Cost Of Revenue	$250.5M	$233.0M
YoY Change	2.0%	37.71%
Gross Profit	$83.30M	$72.90M
YoY Change	49.02%	53.47%
Gross Profit Margin	24.96%	23.83%
Selling, General & Admin	$29.20M	$28.00M
YoY Change	32.73%	22.27%
% of Gross Profit	35.05%	38.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$600.0K	$800.0K
YoY Change	-25.0%	14.29%
% of Gross Profit	0.72%	1.1%
Operating Expenses	$29.20M	$28.00M
YoY Change	32.73%	22.27%
Operating Profit	$54.10M	$44.90M
YoY Change	59.59%	82.52%
Interest Expense	$5.000M	$6.300M
YoY Change	150.0%	270.59%
% of Operating Profit	9.24%	14.03%
Other Income/Expense, Net
YoY Change
Pretax Income	$58.90M	$51.20M
YoY Change	64.07%	83.51%
Income Tax	$13.90M	$13.00M
% Of Pretax Income	23.6%	25.39%
Net Earnings	$45.00M	$38.20M
YoY Change	67.29%	83.65%
Net Earnings / Revenue	13.48%	12.49%
Basic Earnings Per Share	$0.90	$0.76
Diluted Earnings Per Share	$0.89	$0.76
COMMON SHARES
Basic Shares Outstanding	49.91M shares	49.91M shares
Diluted Shares Outstanding	50.63M shares	50.46M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$416.2M	$458.9M
YoY Change	45.17%	112.06%
Cash & Equivalents	$416.2M	$458.9M
Short-Term Investments
Other Short-Term Assets	$9.900M	$12.50M
YoY Change	-41.07%	-30.94%
Inventory
Prepaid Expenses
Receivables	$28.50M	$28.40M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$454.6M	$499.8M
YoY Change	58.56%	101.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.130B	$5.800M
YoY Change	6.85%	3.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$500.0K	$500.0K
YoY Change	0.0%	0.0%
Other Assets
YoY Change
Total Long-Term Assets	$2.144B	$2.034B
YoY Change	4.61%	-2.8%
TOTAL ASSETS
Total Short-Term Assets	$454.6M	$499.8M
Total Long-Term Assets	$2.144B	$2.034B
Total Assets	$2.599B	$2.534B
YoY Change	11.23%	8.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.70M	$65.30M
YoY Change	-8.86%	-10.55%
Accrued Expenses	$141.4M	$128.3M
YoY Change	-3.94%	5.25%
Deferred Revenue	$5.700M	$9.200M
YoY Change	-50.0%	-34.75%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$355.8M	$352.5M
YoY Change	3.13%	-2.03%
LONG-TERM LIABILITIES
Long-Term Debt	$705.7M	$705.3M
YoY Change	-0.16%	-0.16%
Other Long-Term Liabilities	$13.50M	$17.00M
YoY Change	-26.63%	-13.27%
Total Long-Term Liabilities	$719.2M	$722.3M
YoY Change	1.75%	-0.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$355.8M	$352.5M
Total Long-Term Liabilities	$719.2M	$722.3M
Total Liabilities	$1.127B	$1.125B
YoY Change	3.52%	0.4%
SHAREHOLDERS EQUITY
Retained Earnings	$758.0M	$713.0M
YoY Change	36.43%	34.86%
Common Stock	$713.9M	$694.8M
YoY Change	3.13%	0.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.472B	$1.408B
YoY Change
Total Liabilities & Shareholders Equity	$2.599B	$2.534B
YoY Change	11.23%	8.23%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$45.00M	$38.20M
YoY Change	67.29%	83.65%
Depreciation, Depletion And Amortization	$600.0K	$800.0K
YoY Change	-25.0%	14.29%
Cash From Operating Activities	-$59.20M	-$156.7M
YoY Change	-183.26%	214.66%
INVESTING ACTIVITIES
Capital Expenditures	$600.0K	$200.0K
YoY Change	200.0%	100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$600.0K	-$200.0K
YoY Change	200.0%	-113.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	17.10M	-$200.0K
YoY Change	-2950.0%	100.0%
NET CHANGE
Cash From Operating Activities	-59.20M	-$156.7M
Cash From Investing Activities	-600.0K	-$200.0K
Cash From Financing Activities	17.10M	-$200.0K
Net Change In Cash	-42.70M	-$157.1M
YoY Change	-160.74%	224.59%
FREE CASH FLOW
Cash From Operating Activities	-$59.20M	-$156.7M
Capital Expenditures	$600.0K	$200.0K
Free Cash Flow	-$59.80M	-$156.9M
YoY Change	-184.34%	214.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	695000000.0	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49909713	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49909713	shares
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28000000.0	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22900000	usd
CY2023Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1600000	usd
CY2023Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	6300000	usd
CY2022Q4	us-gaap	Interest And Other Income InterestAndOtherIncome	1700000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	51200000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	27900000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000000.0	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7100000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	38200000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	20800000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50100000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49900000	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50500000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49900000	shares
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1369900000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	38200000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	200000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	900000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1408800000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1199300000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	20800000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2022Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	100000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	600000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1220600000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	38200000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	20800000	usd
CY2023Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	800000	usd
CY2022Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	700000	usd
CY2023Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	500000	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2200000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	900000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	600000	usd
CY2023Q4	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	200000	usd
CY2022Q4	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	2400000	usd
CY2023Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1600000	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	209800000	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	49900000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	900000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1800000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-900000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8600000	usd
CY2023Q4	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4200000	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-24300000	usd
CY2023Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	19500000	usd
CY2022Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10500000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-156700000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-49800000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	200000	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100000	usd
CY2023Q4	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	usd
CY2022Q4	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	1600000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-200000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1500000	usd
CY2023Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	200000	usd
CY2022Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	100000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-200000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-157100000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48400000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	616000000.0	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	264800000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	458900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	216400000	usd
CY2023Q4	us-gaap	Notes Issued1 NotesIssued1	9900000	usd
CY2022Q4	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7600000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	12500000	usd
CY2023Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	15700000	usd
CY2023Q4	us-gaap	Deposits Assets DepositsAssets	8200000	usd
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2023Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	2009800000	usd
CY2023Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1790300000	usd
CY2023Q4	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	228000000	usd
CY2023Q4	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	226500000	usd
CY2023Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q4	for	Due Diligence Write Offs DueDiligenceWriteOffs	200000	usd
CY2022Q4	for	Due Diligence Write Offs DueDiligenceWriteOffs	2400000	usd
CY2023Q3	us-gaap	Deposits Assets DepositsAssets	7000000.0	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	1800000	usd
CY2023Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	2000000.0	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	58800000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	58000000.0	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	5600000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	11200000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1300000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	6700000	usd
CY2023Q4	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	400000	usd
CY2022Q4	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	3300000	usd
CY2023Q4	us-gaap	Revenues Revenues	305900000	usd
CY2022Q4	us-gaap	Revenues Revenues	216700000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1300000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	6700000	usd
CY2023Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	58500000	usd
CY2022Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	52500000	usd
CY2023Q4	us-gaap	Interest Costs Incurred InterestCostsIncurred	8100000	usd
CY2022Q4	us-gaap	Interest Costs Incurred InterestCostsIncurred	8200000	usd
CY2023Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	6100000	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	5000000.0	usd
CY2023Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	60500000	usd
CY2022Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	55700000	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	28400000	usd
CY2023Q3	us-gaap	Other Receivables OtherReceivables	25700000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7900000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	2300000	usd
CY2023Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	7900000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8400000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	8100000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6900000	usd
CY2023Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	7000000.0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9200000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10000000.0	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	4100000	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	4100000	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	18000000.0	usd
CY2023Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	4400000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	5200000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	4800000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	3700000	usd
CY2023Q3	us-gaap	Other Liabilities OtherLiabilities	3700000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	63400000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	61200000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	705300000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	695000000.0	usd
CY2023Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	410000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	600000000	usd
CY2023Q4	for	Letterof Credit Maximum Borrowing Capacity LetterofCreditMaximumBorrowingCapacity	100000000	usd
CY2023Q4	for	Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment	0.50
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	24300000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	385700000	usd
CY2020Q2	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	usd
CY2023Q4	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.47
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	900000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	600000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	38200000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	20800000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50065832	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49890481	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	396250	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8541	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50462082	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49899022	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13000000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7100000	usd
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.254
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.254
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	49300000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	900000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	50200000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	49800000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	900000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	50700000	usd
CY2021Q4	for	Equity Securities Registered Value EquitySecuritiesRegisteredValue	750000000	usd
CY2021Q4	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	300000000	usd
CY2023Q4	for	At The Market Equity Offering Program Common Stock Issued AtTheMarketEquityOfferingProgramCommonStockIssued	0	shares
CY2023Q4	for	Common Stock Availablefor Issuance Value Remaining CommonStockAvailableforIssuanceValueRemaining	748200000	usd
CY2023Q4	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	298200000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	24000	shares
CY2023Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	24300000	usd
CY2023Q4	us-gaap	Special Assessment Bond SpecialAssessmentBond	669100000	usd
CY2023Q4	us-gaap	Deposits Assets DepositsAssets	8200000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	483900000	usd
CY2023Q4	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	300000	usd
CY2022Q4	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	600000	usd
CY2023Q4	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	55400	lot
CY2023Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	52400	lot
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	458900000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	705300000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	695000000.0	usd
CY2023Q4	ecd	Insider Trd Policies Proc Adopted Flag InsiderTrdPoliciesProcAdoptedFlag	false

Files In Submission

Name	View Source	Status
for-20231231_lab.xml	Edgar Link	unprocessable
for-20231231_def.xml	Edgar Link	unprocessable
for-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
for-20231231_pre.xml	Edgar Link	unprocessable
0001406587-24-000008-index-headers.html	Edgar Link	pending
0001406587-24-000008-index.html	Edgar Link	pending
0001406587-24-000008.txt	Edgar Link	pending
0001406587-24-000008-xbrl.zip	Edgar Link	pending
a12312023exhibit311.htm	Edgar Link	pending
a12312023exhibit312.htm	Edgar Link	pending
a12312023exhibit321.htm	Edgar Link	pending
a12312023exhibit322.htm	Edgar Link	pending
a23dec20danielbartokconsul.htm	Edgar Link	pending
a23dec20danielbartoksepara.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
for-20231231.htm	Edgar Link	pending
for-20231231.xsd	Edgar Link	pending
for-20231231_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
for-20231231_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOR
Forestar Group Inc. Stock $for

2024 Q1 Form 10-Q Financial Statement

#000140658724000008 Filed on January 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR Forestar Group Inc. Stock $for

2024 Q1 Form 10-Q Financial Statement

#000140658724000008 Filed on January 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR
Forestar Group Inc. Stock $for